Professor Christopher M Nutting BSc MBBS MD PhD FRCP FRCR ECMO MedFIPEM
Professor of Oncology, The Royal Marsden Hospital
Prof Christopher Martin Nutting qualified from Portsmouth Grammar School in 1986 and from University College and Middlesex Hospital School of Medicine (University of London) in 1992. He was awarded 1st Class BSc Honours (Medicine and Cell Pathology, University of London) in 1989 and MB BS (University of London) 1992. He became a Member of the Royal College of Physicians (UK) 1995 and Fellow of the Royal College of Radiologists (UK) in 1998. In 1999 he was awarded Certification of European Society of Medical Oncology. Following a period of study at Imperial College Business School he was awarded the Advanced Certificate in Health Care Management (University of London) in 2000. Between 1998 and 2001 he studied for a Medical Doctorate (MD Res) at The Institute of Cancer Research, University of London, which he was awarded in 2001. He was awarded PhD from City University in 2012.
He was appointed Consultant Clinical Oncologist at the Royal Marsden Hospital and Honorary Senior Lecturer in Clinical Oncology at the Institute of Cancer Research in 2001. He was appointed Teacher of the University of London and Clinical Director of the Head and Neck Unit at the Royal Marsden Hospital in 2002. In 2003 he was appointed National Clinical Lead in Head and Neck Cancer by the Department of Health (UK) and the Cancer Services Collaborative. In addition, he has been a member of the National Cancer Research Institute Committee (NCRI) Head and Neck Cancer Clinical Studies Group (CSG) since 2003 and became Chairman of the CSG in 2006. During his period as Chairman (2006-20012) the CSG became the highest performing rare cancer with an increase in national clinical trial recruitment to record levels. He was appointed as National Clinical Oncology advisor to the Data for Head and Neck Oncology (DAHNO) project in 2005. He is Chairman of the National Advisory Board on Head and Neck Cancer to the Cancer Services Collaborative (DoH). In 2007 he became President of the British Oncological Association, and was elected Honorary Faculty member at The Institute for Cancer Research. In 2009 he was appointed Co-Chair of The Clinical and Translational Radiotherapy and Radiobiology Working Group of the NCRI. Also in that year he was made Reader in Clinical Oncology (University of London). He is a Module leader for the Institute of Cancer Research MSc program.
Professor Nutting is Principal Investigator for a number of research trials including the Cancer Research UK sponsored PARSPORT, COSTAR, and ARTDECO Trials. He is joint holder of CRUK program grant "Physical and biological optimisation of radiotherapy in head and neck cancer". He is principle or co-investigator on an additional 15 trials in head and neck cancer sponsored by the Royal Marsden Hospital or by the pharmaceutical industry. He is Principal and/or Co-investigator of research grants for advancement of radiotherapy and chemotherapy research from Cancer Research UK, HTA, and the pharmaceutical industry. As a regular contributor to International medical publications and meetings, he has published over 150 articles in his areas of expertise. He has received National and International Awards and Professorships for his advances in research into head and neck cancer radiotherapy.